Elite Penny Stocks

Results

21

Most penny stocks fail because they run out of cash. We handpicked only the most elite penny stocks that have the balance sheets to actually reach their growth targets. If you want to find the next multi-bagger, this is a great place to start.

21 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
NEPH
US$4.41-6.1%9.6%US$51.7mUS$6.2527.633.2%n/aCapital Goods
INMB
US$2.16-0.5%-10.4%US$60.2mUS$7.002.943.4%n/aPharmaceuticals & Biotech
MCHX
US$1.78-2.2%-8.2%US$78.4mUS$4.001.8191.5%0%Media
YSG
US$2.98-12.4%-69.0%US$277.7mUS$4.000.4146.1%n/aHousehold
MNOV
US$1.374.6%4.4%US$67.2mUS$9.0073.371.2%n/aPharmaceuticals & Biotech
SIGA
US$2.973.1%-66.1%US$223.5mn/a4.0201.1%20.2%Pharmaceuticals & Biotech
CLOV
US$4.10-8.7%57.1%US$2.2bUS$5.170.944.5%n/aHealthcare
FTEK
US$1.38-4.8%-48.7%US$43.7mUS$4.001.669.8%n/aCommercial Services
KRMD
US$3.27-1.7%-20.4%US$153.3mUS$6.603.3109.2%n/aHealthcare
FKWL
US$2.410.8%-42.8%US$28.6mUS$6.000.874.2%1.7%Tech
REAX
US$2.7514.6%-38.3%US$611.6mUS$4.950.360.3%n/aReal Estate Management and Development
LSF
US$4.10-6.4%-26.8%US$47.7mUS$7.170.6180.6%n/aFood, Beverage & Tobacco
ALDX
US$1.50-3.8%-74.2%US$90.5mUS$6.602.455.2%n/aPharmaceuticals & Biotech
RERE
US$4.08-11.3%-12.3%US$1.0bUS$6.8814.132.9%2.5%Retail
CMRC
US$2.252.7%-53.6%US$186.4mUS$4.000.5113.6%n/aSoftware
MSGM
US$3.80-14.4%29.6%US$16.1mUS$9.006.831.5%n/aMedia
GRAB
US$3.51-3.0%-31.6%US$14.3bUS$5.8623.922.1%n/aTransportation
NIU
US$2.00-5.2%-57.0%US$163.9mUS$2.530.2108.3%n/aAutomobiles
ZJK
US$1.823.4%-44.2%US$116.1mn/a11.535.7%n/aCapital Goods
CMPX
US$2.364.9%-21.9%US$426.8mUS$8.922.656.1%n/aPharmaceuticals & Biotech
PPSI
US$2.88-4.6%-20.4%US$32.2mUS$9.501.571.9%n/aCapital Goods
Page 1 of 1